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1  | INTRODUC TION
Burgeoning research regarding the role of the gut and its microbial 
inhabitants in the pathophysiology of psychological illness is gain‐
ing momentum. Early evidence points to gut microbiota (GM) as a 
possible missing link in the conceptualization and treatment of psy‐
chological illness that sees disparities between conventional treat‐
ment methods and prevalence rates. When discussing the role of 
GM in behavior, health, and disease, it is important to pay respect 
to the intertwined coevolution between humans and our resident 
microbes. It is suggested that the sharp increase in various disease 
states over the last 50–100 years (Campell, 2014; Linneberg et al., 
2000) can be, at least in part, explained by relatively recent dietary 
and lifestyle changes in the context of human evolution (Broussard 
& Devkota, 2016). Currently, humans, particularly those in indus‐
trialized countries, are living in an environment to which they have 
not adaptively evolved (Gluckman, Low, Buklijas, Hanson, & Beedle, 
2011). An unintended consequence of industrialization, these 
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Abstract
Introduction: The prevalence of psychological disorders remains stable despite 
steady increases in pharmacological treatments suggesting the need for auxiliary 
treatment options. Consideration of the brain–gut–microbiota axis (BGMA) has made 
inroads into reconceptualizing psychological illness from a more holistic perspective. 
While our understanding of the precise role of gut microbiota (GM) in psychological 
illness is in its infancy, it represents an attractive target for novel interventions.
Method: An extensive review of relevant literature was undertaken.
Results: Gut microbiota are proposed to directly and indirectly influence mood, cog‐
nition, and behavior which are key components of mental health. This paper outlines 
how GM may be implicated in psychological disorders from etiology through to treat‐
ment and prevention using the Four P model of case formulation.
Conclusion: Moving forward, integration of GM into the conceptualization and treat‐
ment of psychological illness will require the discipline of psychology to undergo a 
significant paradigm shift. While the importance of the GM in psychological well‐
being must be respected, it is not proposed to be a panacea, but instead, an additional 
arm to a multidisciplinary approach to treatment and prevention.
K E Y W O R D S
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changes are putting the GM under evolutionary pressure to shift 
from a previously mutualistic relationship with their human host to 
a more antagonistic one (Broussard & Devkota, 2016; Quercia et al., 
2014). This is due to human evolution requiring significantly more 
time (Uyeda, Hansen, Arnold, & Pienaar, 2011) compared to single‐
celled organisms such as GM that evolve and adapt to environmental 
and internal states much more rapidly (within as little as 24 hr; David 
et al., 2014; Wu et al., 2011). These variations in the evolutionary 
pressures and capabilities of the two components (host and GM) of a 
single ecosystem (the holobiont; Theis et al., 2016) result in systemic 
disharmony.
This systemic disharmony leads to symptomatology and disease 
states that are the primary target for intervention in current medi‐
cal models, which precludes effective etiology‐focused prevention 
(Marvasti & Stafford, 2012). This is exacerbated given that current 
medical models are heavily skewed toward treatment over preven‐
tion (Singh, 2010). While there is disagreement over whether the 
occurrence of common mental disorders are increasing or whether 
their prevalence remains consistent (Friedrich, 2017; Harvey et al., 
2017), the consumption of antidepressant drugs doubled in most, if 
not all, Organisation for Economic Co‐operation and Development 
(OECD) countries between 2000 and 2015 (OECD, 2017). Despite 
this, depression has recently taken over as the leading cause of dis‐
ability worldwide with anxiety also in the top 10 leading causes of 
disability (World Health Organisation (WHO) 2017). Furthermore, 
subclinical psychological symptoms that do not meet the full 
Diagnostic and Statistical Manual for Mental Disorders (DSM) or 
International Classification of Diseases (ICD) diagnostic criteria are 
also prevalent (Angst, Merikangas, & Preisig, 1997; Haller, Cramer, 
Lauche, Gass, & Dobos, 2014; Mathieson, Collings, & Dowell, 2009). 
These subclinical symptoms lead to impairment in psychosocial and 
work functioning, are a major determinant of sick leave, contribute 
to the use of psychotropic drugs and primary health care services, 
and reduce quality of life (Haller et al., 2014; Johansen & Dittrich, 
2013; Mendlowicz & Stein, 2000).
The conceptualization of the human body as being made up of 
separate and distinguishable systems is likely to have contributed 
to our current poor appreciation of the complexity of mechanisms 
that underlie the etiology and progression of disease. Psychology, 
just like many other healthcare professions and medical science dis‐
ciplines, specialize and focus on specific body systems. For example, 
treatment of psychological symptoms and disorders tends to be cen‐
tral nervous system (CNS)‐centric with the brain being the principle 
target for both psychotherapy and psychopharmacology while pe‐
ripheral systems, such as the gut, receive little attention. While there 
is no doubt that specialization has its benefits and has contributed 
to the progression of medical knowledge, it also has its drawbacks. 
Operating within these constrictive distinctions imposed by disci‐
plinary specialization means that the complex interplay between 
various body systems essential to proper functioning is overlooked. 
The true etiology of disease is likely to come from dysregulations in 
this interplay which may also go some way to explaining high lev‐
els of comorbidity, particularly between functional gastrointestinal 
disorders such as IBS and psychological conditions (Garakani et al., 
2003; Lee et al., 2015).
Within the field of psychology, an integral part of intervention is 
case formulation. Essentially, case formulation involves the synthe‐
sis of information about a patient (typically gained through clinical 
interviews and formalized cognitive testing) in a meaningful way to 
facilitate the development of a treatment plan. A commonly used 
model in structuring a case formulation is that of the Four Ps which 
represent the predisposing, precipitating, perpetuating, and pro‐
tective factors related to a client's presenting problem and thus the 
targets of psychological intervention. As information is drawn from 
clinical interviews and cognitive testing, the functioning of a client's 
gut is seldom considered in their formulation; thus, important diag‐
nostic and treatment options may be missed. It is the contention of 
this paper to demonstrate that GM are intimately linked with each of 
these four pillars of psychological intervention and thus each stage 
of disease, from etiology through to treatment and prevention. This 
paper adds to the burgeoning research into the brain–gut–microbi‐
ota axis (BGMA; Kelly, Clarke, Cryan, & Dinan, 2016) demonstrat‐
ing that the discipline of psychology is on the cusp of a significant 
paradigm shift, moving away from CNS‐centric approaches toward 
a more holistic conceptualization of health and disease which inte‐
grates other body systems. We echo the sentiment of Allen, Dinan, 
Clarke, and Cryan (2017) who call for a challenge to the reductionist 
approaches in psychology in favor of a multidisciplinary approach to 
conceptualizing and treating psychological disorders. In taking the 
unique approach of the Four P model of case formulation, this paper 
intends to review existing research on associations between GM and 
psychological outcomes, compiling it in a way that is more accessible 
to psychologists, especially those who have little previous knowl‐
edge regarding the BGMA.
1.1 | The brain–gut–microbiota axis
The BGMA is increasingly being recognized as playing an important 
role in homeostasis and consequentially, health and disease states 
(e.g., Mu, Yang, & Zhu, 2016; Rea, Dinan, & Cryan, 2016). The BGMA 
refers to the relationship between the brain and the gut while ac‐
knowledging the important moderating role of GM (e.g., Carabotti, 
Scirocco, Maselli, & Severi, 2015; Grenham, Clarke, Cryan, & Dinan, 
2011). Largely recognized as a bidirectional relationship (e.g., Rhee, 
Pothoulakis, & Mayer, 2009), research continues to uncover the true 
complexities of this communication network which Rea et al. (2016) 
more accurately define as a multidirectional relationship. It is multi‐
directional in the sense that each component of this extensive com‐
munication network has the ability to moderate and manipulate the 
function of the other systems involved. Communication between 
the brain and the gut is maintained via a complex network including 
the CNS, autonomic nervous system (ANS), enteric nervous system 
(ENS), hypothalamic–pituitary–adrenal (HPA) axis, neural, endocrine 
and immune systems (e.g., Carabotti et al., 2015; Cryan & Dinan, 
2012; Mayer, 2011; Moloney, Desbonnet, Clarke, Dinan, & Cryan, 
2014). Essentially, the BGMA provides a network for signals from 
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the brain to influence the motor, sensory, and secretory functions 
of the gut while simultaneously allowing signals and metabolites 
from the GM to influence brain development, biochemistry, func‐
tion, and behavior (e.g., Cryan & O'Mahony, 2011; Grenham et al., 
2011; Marques et al., 2014). This communication system presents an 
exciting and novel target for psychological intervention, providing a 
deeper understanding of the biological underpinnings of psychologi‐
cal illnesses. It is hoped that developing a greater understanding of 
the BGMA as it relates to the Four Ps of case formulation will provide 
psychologists with an additional tool in the treatment of their clients.
1.2 | Is diet the chicken, or the egg?
The relationship between diet and GM is an intriguing one, ironically 
reminiscent of the idiom regarding which came first, the chicken or 
the egg. Once thought to be unidirectional (diet influencing the com‐
position of the microbiota), recent evidence suggests the relation‐
ship could in fact be bidirectional, with microbes also being able to 
influence food choice and dietary‐related behaviors (Alcock, Maley, 
& Aktipis, 2014).
Diet is arguably one of the most important environmental fac‐
tors in shaping the composition and metabolic activities of GM (De 
Filippo et al., 2017; Garcia‐Mantrana, Selma‐Royo, Alcantara, & 
Collado, 2018; Voreades, Kozil, & Weir, 2014). As such, diet must 
be taken into consideration when discussing potential interventions 
involving GM. An extensive review of the relationship between diet 
and GM is beyond the scope of this paper, but can be found else‐
where (e.g., Sheflin, Melby, Carbonero, & Weir, 2017; Singh et al., 
2017; Wu et al., 2011). Here, diet is discussed insofar as to high‐
light to psychologists the importance of this environmental factor 
in the formulation and treatment of their client's presenting prob‐
lem. While it is not being suggested that psychologists become well 
versed in dietetics, gathering general information on a client's diet 
may provide further insight into the development and perpetuation 
of their presenting problem, and presents as an additional arm to a 
multidisciplinary and holistic treatment approach.
Both the content and diversity of an individual's diet are be‐
lieved to be important in maintaining a well‐balanced GM (Heiman & 
Greenway, 2016; Oriach, Robertson, Stanton, Cryan, & Dinan, 2016). 
Diet quality has also been highlighted as a potential risk or protective 
factor for conditions such as depression (Jacka et al., 2017; Koopman 
& El Aidy, 2017; Lai et al., 2014). In regards to dietary content, the 
industrial revolution saw a significant increase in highly processed 
cereals rich in carbohydrates, refined sugars, sodium, omega‐6, and 
trans‐fatty acids. Concurrently, potassium, complex carbohydrates, 
fiber, omega‐3, and unsaturated fatty acids were considerably re‐
duced (Rubio‐Ruiz, Peredo‐Escárcega, Cano‐Martínez, & Guarner‐
Lans, 2015). These changes are reflective of what is today termed 
the “Western‐style diet,” one that has been shown to impair immune 
function and promote inflammation (Myles, 2014). This is concerning 
given that inflammation is believed to underlie and perpetuate many, 
if not all, psychological and neurodegenerative illnesses (Almond, 
2013; Miller & Raison, 2016; Rea et al., 2016). Worryingly, dietary 
diversity has been further reduced over the past 50 years with an 
ever increasing preference for convenience and taste (Glanz, Basil, 
Maibach, Goldberg, & Snyder, 1998; Heiman & Greenway, 2016; 
Poti, Mendez, Ng, & Popkin, 2015). Essentially, this means that 
current human diets are not providing GM with the resources they 
require to perform their myriad of complex tasks involved in host 
homeostasis and consequently health and disease. Adding support 
to this contention, Jacka et al. (2017) conducted a clinical trial which 
demonstrated that adherence to a modified Mediterranean diet 
resulted in significantly greater improvement in depression ratings 
from baseline compared to a social support control group.
While diet is one way through which a host can modulate their 
GM, microbes are themselves able to influence eating behaviors of 
their host (Alcock et al., 2014). Microbes in the gut must cooper‐
ate and share limited resources (space and nutrients) to promote 
stable coexistence and ecological diversity (Allen & Nowak, 2013). 
This means that these microorganisms are under selective pres‐
sure to ensure their own survival and must therefore compete for 
available resources (Hibbing, Fuqua, Parsek, & Peterson, 2010). As 
such, microbes are proposed to manipulate the eating behavior of 
the host by either generating cravings for foods that they thrive on 
or those which suppress their competitors, or by influencing mood 
which leads to the intake of foods that enhance that species' fitness 
(Alcock et al., 2014; Leitao‐Goncalves et al., 2017).
1.2.1 | Dietary‐derived short‐chain fatty acids
A continued loss of fiber from the Western diet will inevitably lead 
to continued depletion of short‐chain fatty acids (SCFAs; Broussard 
& Devkota, 2016) with downstream effects on the development and 
perpetuation of psychological illnesses through their immunoregula‐
tory effects (Rogers et al., 2016). SCFAs (acetic, butyric, and pro‐
pionic acids in particular) are one of the main metabolites of GM 
(Carabotti et al., 2015; Smith et al., 2013). They are the end products 
of dietary fiber fermentation and have been shown to have many 
beneficial effects on host health (Bourassa, Alim, Bultman, & Ratan, 
2016; den Besten et al., 2013).
In the brain, SCFAs demonstrate neuroprotective properties 
(Sun et al., 2015) with butyrate in particular having a protective ef‐
fect on psychological and neurodegenerative disorders (Bourassa 
et al., 2016). Peripherally, SCFAs are believed to influence the 
size and function of regulatory T cells which play a crucial role 
in regulating inflammation and immune homeostasis (Hakansson 
& Molin, 2011; Smith et al., 2013). Additionally, SCFAs (together 
with enzymes also produced by the GM) enhance intestinal bar‐
rier functioning through their regulation of tight junction (TJ) pro‐
teins (e.g., Anderson et al., 2010; Bischoff et al., 2014; Peng, Li, 
Green, Holzman, & Lin, 2009). Abnormal intestinal permeability 
(leaky gut) results in increased translocation of toxins and GM 
across the epithelial barrier which consequently trigger an inflam‐
matory immune response that can dysregulate ENS and systemic 
immune functioning (Berkes, Viswanathan, Savkovic, & Hecht, 
2003; Carabotti et al., 2015; Fasano, 2012; Smith et al., 2013). 
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This immune response is believed to be the instigator of resultant 
symptom expression including psychological disorders such as de‐
pression (e.g., Maes et al., 2013; Mulak & Bonaz, 2015; Sheedy et 
al., 2009).
Also via their influence on TJ proteins, SCFAs are believed to reg‐
ulate the permeability of the blood–brain barrier (BBB; Braniste et 
al., 2014). Dysregulation of the BBB has been associated with neu‐
ropsychological conditions including Alzheimer's disease (Kuhnke 
et al., 2007) and autism (Fiorentino et al., 2016). Schoknecht and 
Shalev (2012) suggest that depression and schizophrenia may also 
be related to BBB dysfunction. Although further research is needed, 
these associations are highly plausible given the BBB is responsi‐
ble for regulating access of circulating macromolecules and poten‐
tial neurotoxins to the brain (Fiorentino et al., 2016; Patel & Frey, 
2015). As evidence of microbial involvement, Braniste et al. (2014) 
found that germ‐free (GF) mice (those devoid of bacterial coloni‐
zation and therefore lacking conventional gut flora) have increased 
BBB permeability compared to specific pathogen‐free (SPF) mice 
that have conventional GM colonization free of any known patho‐
gens. Colonization of GF mice with known SCFA‐producing bacterial 
strains (Clostridium tyrobutyricum and Bacteroides thetaiotaomicron) 
was found to normalize BBB function (Braniste et al., 2014). There 
is also evidence to suggest that SCFAs are involved in glucose me‐
tabolism, reducing adiposity, appetite regulation, and energy ho‐
meostasis (Byrne, Chambers, Morrison, & Frost, 2015; Chambers et 
al., 2015; Kondo, Kishi, Fushimi, Ugajin, & Kaga, 2009; Morrison & 
Preston, 2016).
1.3 | Behavior
Studies using GF mice have provided the greatest depth of infor‐
mation regarding the influence of GM on host behavior. Such pre‐
clinical work gives useful insights into the physiological mechanisms 
through which the BGMA functions. For example, GF mice dem‐
onstrate altered expression of brain‐derived neurotrophic factor 
(BDNF) and SCFA while also exhibiting altered HPA axis functioning, 
anxious and depressive behaviors, and social functioning (Arentsen, 
Raith, Qian, Forssberg, & Diaz Heijtz, 2015; Luczynski et al., 2016; 
Neufeld, Kang, Bienenstock, & Foster, 2011; Sudo et al., 2004). 
In both animal and human models, manipulation of GM has also 
been demonstrated to alter levels of stress hormones corticotro‐
pin‐releasing factor (CRF) and cortisol (Yarandi, Peterson, Treisman, 
Moran, & Pasricha, 2016). Many of these abnormalities have been 
shown to be rectified by colonization with the feces from SPF mice 
or with specific probiotics (e.g., Bercik et al., 2011; Desbonnet et al., 
2010; Sudo et al., 2004). However, Bravo et al. (2011) found that 
ingestion of probiotics was only beneficial in mice which had an in‐
tact vagus nerve, demonstrating the importance of the vagal path‐
way in brain–gut communication. Additionally, Sudo et al. (2004) 
demonstrated that recolonization was only effective if it occurred 
within a critical period, providing evidence for a fundamental role 
of GM in the development of crucial systems involved in behavioral 
outcomes.
A recently proposed way in which GM may manipulate host 
behavior is via their relationship with personality traits. Kim et al. 
(2018) found an increased abundance of Gammaproteobacteria in 
those with high neuroticism, as well as those with low extraversion. 
Low conscientiousness was associated with an increased abundance 
of Proteobacteria and a decreased abundance of Lachnospiraceae 
while those with high levels of openness demonstrated greater phy‐
logenic diversity and richness (Kim et al., 2018). As this was the first 
study to have investigated the link between GM and personality di‐
rectly, further research is required to elucidate these relationships. 
The relationship between personality and GM presents as an intrigu‐
ing area of exploration, given that personality traits have a strong 
association with behavioral patterns in addition to physiological 
and psychological health outcomes (e.g., Ferguson, 2013; Kim et al., 
2018; Srivastava & Das, 2015).
Additional evidence linking GM composition and behavior comes 
from the study of patients following gastric bypass surgery. Behavioral 
changes following gastric bypass surgery include patients feeling less 
hungry and having a preference for healthier foods (Behary & Miras, 
2015) which is likely related to changes in neural responses to food 
(particularly high‐calorie foods) in key areas of the mesolimbic re‐
ward pathway (Ochner et al., 2011, 2012). It is tempting to speculate 
that these changes are associated with the compositional changes 
in GM following gastric bypass surgery (Furet et al., 2010; Liou et 
al., 2013; Zhang et al., 2009). Additionally, improvements in qual‐
ity of life and levels of depression have been shown to persist two 
years after surgery (Karlsson, Sjostrom, & Sullivan, 1998; Mokhber, 
Shaghayegh, Talebi, & Tavassoli, 2016). These improvements may be 
the result of reduced adipose tissue which has downstream effects 
on GM and their role in inflammation and other related functions. 
While causational evidence is currently unavailable, correlational re‐
search linking GM and mood (Jiang et al., 2015) suggest that changes 
in GM composition following gastric bypass surgery may also have a 
direct influence on mood. Improvements in mood may consequently 
encourage healthier food choices and eating behaviors (Christensen 
& Brooks, 2006), exemplifying the potential for a cyclical relationship 
involving diet, GM, and mood that is beneficial to overall health.
Given the possible role of GM in eating behaviors, and their 
ability to influence hunger and satiety (Cani et al., 2009) and neuro‐
peptide and endocrine regulation (Holzer & Farzi, 2014), a relatively 
new line of inquiry has emerged investigating GM involvement in 
eating disorders which are traditionally recognized as psychological 
disorders (Kleiman et al., 2015; Lam, Maguire, Palacios, & Caterson, 
2017). Associations between GM composition and eating disorder 
psychopathology were also found by Kleiman et al. (2015), further 
suggesting that the GM play a role in the psychology of food choice 
and eating behaviors. Given that diet is a key determinant of GM 
composition and that eating disorders are categorized by extreme 
dietary changes, the GM present as a logical target for inclusion in 
multifaceted intervention.
While this paper focuses mainly on unconscious mechanisms un‐
derlying the relationship between GM and psychological outcomes 
(such as interoceptive processes and neurotransmitter production), it 
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is acknowledged that conscious mechanisms also have potential psy‐
chological implications. For example, gastrointestinal symptoms can 
be noticeably unpleasant and, particularly in IBS sufferers, can lead to 
impairment in daily functioning (Ballou, Bedell, & Keefer, 2015), anxi‐
ety and depression (Roohafza et al., 2016), avoidance behaviors (Van 
Oudenhove et al., 2016), and poor quality of life (Canavan, West, & 
Card, 2015). Conscious mechanisms can also lead to positive psycho‐
logical outcomes as exemplified by patients following gastric bypass 
surgery. For example, noticeable changes in body composition can 
result in more positive body image which in itself is related to psycho‐
logical well‐being, particularly after body contouring surgery (Jumbe, 
Hamlet, & Meyrick, 2017; Sarwer & Steffen, 2015; Song et al., 2016). 
These changes can then encourage long‐term weight loss maintenance 
behavior (Palmeira et al., 2010).
1.4 | Neurotransmitters
Perhaps the most obvious association between GM and psychologi‐
cal illnesses is the ability of GM to manipulate the production and 
action of several key neurotransmitters (e.g., Anderson & Maes, 
2015; Lyte, 2011; O'Mahony, Clarke, Borre, Dinan, & Cryan, 2015). 
GM regulate the metabolism and concentration of amino acids which 
serve as precursors for several neurotransmitters including gamma‐
aminobutyric acid (GABA), serotonin, melatonin, and dopamine, 
among others (Clarke et al., 2014; Evrensel & Ceylan, 2015; Jenkins, 
Nguyen, Polglaze, & Bertrand, 2016; Zagajewski et al., 2012). As 
such, it is highly plausible that GM are able to influence brain chemis‐
try, which consequentially regulates cognition, mood, and behavior. 
As depicted in Figure 1, demonstrating bidirectionality, GM can also 
be directly affected by neurochemicals which alter bacterial growth 
and pathogenicity (Lyte, 2011). Table 1 displays some of the key neu‐
rotransmitters synthesized by GM whose dysregulation is associated 
with psychological disorders. While neurotransmitters produced in 
the gut may not directly influence brain chemistry as they do not 
pass through the BBB, they are able to influence the CNS through 
mechanisms including direct stimulation of the vagus nerve, as well 
as using indirect circulatory and immune pathways (Sampson & 
Mazmanian, 2015). For example, tryptophan, the precursor molecule 
F I G U R E  1   Factors influencing the multidirectional communication between the brain and the gut. Double‐headed arrows demonstrate 
a bidirectional relationship, with broken arrows demonstrating proposed but not yet established relationships. The figure demonstrates 
the three main well‐established pathways of communication between the brain and the gut, being endocrinological, neuronal, and 
immunological. The figure also illustrates the bidirectional relationships between microbial dysbiosis and the HPA axis, neurotransmitter 
production, the function of the blood–brain barrier, and inflammation which are believed to alter their functioning as an allostatic response 
to homeostatic emotions. It is proposed that microbial dysbiosis itself is able to be detected via the interoceptive system which then triggers 
these homeostatic emotions
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to serotonin (which is itself the precursor to melatonin), is able to 
pass through the BBB and as such it is likely that metabolites of GM 
directly influence brain chemistry (Sampson & Mazmanian, 2015).
1.5 | Interoception and allostatic responses
It is currently unknown whether the interoceptive system is able 
to detect microbial dysbiosis (imbalances resulting from the under‐ 
or overabundance of certain microbial species; DeGruttola, Low, 
Mizoguchi, & Mizoguchi, 2016), but considering that gut microbes 
are an essential part of human physiology which moderate sev‐
eral homeostatic emotions (Craig, 2002; Mayer, Naliboff, & Craig, 
2006; Noakes, 2012; Paulus & Stein, 2010) it is a strong possibility. 
Homeostatic emotions are background emotions that may or may 
not enter conscious awareness but influence an individual's energy 
levels, mood, and disposition (Mayer et al., 2006). Signals from in‐
ternal organs, particularly the gut, continuously communicate with 
various regions of the brain including the limbic system, autonomic 
and neuroendocrine centers in the hypothalamus, brainstem, and 
cortex (Craig, 2002; Holzer & Farzi, 2014; Mayer & Tillisch, 2011). 
It is plausible that through the process of interoception, GM are 
able to influence human cognition, emotion, and mood through 
their involvement in systemic functioning through their various me‐
tabolites (Holzer, 2017; Paulus & Stein, 2010). As such, increasing 
rates of disease might be explained by the allostatic load hypoth‐
esis (McEwen, 1998). The allostatic load hypothesis proposes that 
rather than having a stable set point, body systems have a range 
of set points allowing them to actively adapt to environmental and 
internal states. Allostatic load is a term used to refer to the cumu‐
lative cost of allostasis to the body (“wear and tear”; McEwen & 
Wingfield, 2003). While adaptive in the short term, allostasis can 
become maladaptive, leading to disease, when allostatic measures 
are required to vary widely and frequently, or are at extreme val‐
ues for long periods of time (James, 2013). Additionally, allostatic 
systems can become dysfunctional when they lose their ability to 
change or regulate change (James, 2013). The result of either of 
these scenarios is allostatic overload which can lead to symptom 
expression, as depicted in Figure 1 (Berger, Juster, & Sarnyai, 2015; 
McEwen, 2005; McEwen & Wingfield, 2003). The fact that research 
has failed to define the precise composition of a healthy GM due 
to immense interindividual differences (Lloyd‐Price, Abu‐Ali, & 
Huttenhower, 2016) suggests that the GM may in fact be the most 
allostatic system within the body. Microbial dysbiosis then could be 
considered an extreme and prolonged shift away from what would 
be considered a relatively healthy composition which loses its abil‐
ity to regulate change in various other host systems and functions. 
It is perhaps this dysregulation that manifests itself in psychological 
illness.
Figure 1 depicts the three overarching pathways (endocrinolog‐
ical, neuronal, and immunological) of bidirectional communication 
between the brain and the gut, each of which is altered during a 
state of microbial dysbiosis. Although it remains unconfirmed, it is 
proposed that microbial dysbiosis can be detected via interoception 
which ultimately leads to altered functioning of factors (e.g., inflam‐
mation) that mediate these pathways. These alterations are believed 
to be an allostatic response to a deviation from a “typical” microbi‐
ome, which over time, leads to symptom expression as a result of 
allostatic overload. The bidirectional relationship between microbial 
dysbiosis and the factors which alter the three main communication 
pathways between the gut and the brain illustrate the multidirec‐
tional nature of the BGMA.
2  | GM THROUGH THE LENS OF A C A SE 
FORMUL ATION FR AME WORK
It is not the intention of this paper to propose that the BGMA must be 
at the forefront of consideration for each and every client. Instead, it 
is proposed that the relevance of the BGMA is determined on a case‐
by‐case basis. The role of the BGMA in a client's presenting prob‐
lem may be less relevant when there are clear social and emotional 
etiological factors, such as the presence of significant stressors for 
a client presenting with anxiety or depression. However, it is worth 
noting that stress can alter the composition of a person's GM (Bailey 
et al., 2011), which may or may not be clinically relevant, but should 
be considered if comorbidities are present. It may also be less rel‐
evant for clients who respond well to traditional psychological treat‐
ments such as cognitive behavioral therapy. Alternatively, cases in 
which the role or the BGMA may be more pertinent are when social 
and emotional etiological factors are less clear or absent, and also 
for clients who do not respond well to conventional psychological 
approaches. In cases where a treating clinician considers investiga‐
tion of the GM to be appropriate, clients should be referred for stool 
sampling and analysis and an open dialogue established between the 
clinician and the microbiologist performing the analysis. The follow‐
ing information serves to highlight possible associations between 
GM and each of the Four Ps.
2.1 | Predisposing
As part of their first line of questioning, mental health professionals 
attempt to explore a client's family history of psychological illness 
to establish whether that individual has an underlying genetic pre‐
disposition (vulnerability) to developing a psychological condition(s). 
Genetic predisposition to a multitude of psychological conditions has 
been well established (Hyman, 2000). While research into the role 
of GM in genetic predisposition is scarce, several lines of evidence 
suggest that GM may play an integral part in a person's vulnerability 
to the development of psychological illnesses. Firstly, host genetics 
have been demonstrated to influence the composition and meta‐
bolic activities of GM (Goodrich et al., 2014; Ussar, Fujisaka, & Kahn, 
2016) which have important consequences on host physiology, brain 
development, and health (e.g., Krishnan, Alden, & Lee, 2015; Sekirov, 
Russell, Antunes, & Finlay, 2010). However, the specific mechanisms 
behind	 this	 relationship	 remain	unclear	 (Dąbrowska	&	Witkiewicz,	
2016).
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2.1.1 | Vertical transmission
Additionally, there is evidence to suggest that much like genetics are 
passed down from parents to offspring, GM are vertically transmit‐
ted from mother to infant (e.g., Asnicar et al., 2017; Mueller, Bakacs, 
Combellick, Grigoryan, & Dominguez‐Bello, 2015). The transmis‐
sion of microbiota from mother to infant during birth represents 
the most important point of microbial colonization in the infant gut, 
which continues over the first three years of life (Yatsunenko et al., 
2012). This critical establishment period of GM is in line with the 
critical development period of the human host (Rea et al., 2016). 
It is during this time that GM play key roles in the development of 
the CNS, HPA axis, and immune system (Borre et al., 2014; Cox et 
al., 2014; Furusawa et al., 2013; Houghteling & Walker, 2015). As 
such, aberrations in typical colonization of GM during this critical pe‐
riod may also result in abnormal development of these key systems 
(Tamburini, Shen, Wu, & Clemente, 2016). Factors resulting in aber‐
rations to conventional microbial colonization of the gut during this 
period, such as birth by cesarean section and antibiotic treatment 
during infancy, have been associated with increased rates of chronic 
and atopic diseases (Kolokotroni et al., 2012; Sevelsted, Stokholm, 
Bonnelykke, & Bisgaard, 2015; Vangay, Ward, Gerber, & Knights, 
2015). A recent study by Polidano, Zhu, and Bornstein (2017) high‐
lights the microbiota as a potentially important factor in the negative 
relationship they found between cesarean birth and a range of cog‐
nitive outcomes compared to those born vaginally.
There is a growing consensus that maternal GM may have long‐
term health consequences for the child (Stanislawski et al., 2017). 
It is therefore reasonable to suggest that vertically transmitted GM 
may act as a mechanism for intergenerational predisposition to psy‐
chological disorders. Further research is required as it is difficult to 
determine whether these intergenerational patterns are due to the 
vertical transmission of GM or whether they are due to learned be‐
haviors and lifestyle factors shared among family members. This is 
evidenced by same‐household members showing a higher similarity 
of GM composition to those outside of the household (Abeles et al., 
2016; Song et al., 2013; Yatsunenko et al., 2012).
2.1.2 | Aging
Aging, in and of itself, can also predispose an individual to several 
psychological illnesses. For example, neurodegenerative illnesses, 
such as Alzheimer's disease, are considered an evolutionary acci‐
dent occurring as a result of increased longevity (Giunta et al., 2008; 
Gluckman et al., 2011; Niccoli & Partridge, 2012). There is evidence 
to suggest that psychological disorders are also more prevalent in 
the elderly (e.g., Andreas et al., 2017). A contributing factor toward 
the increased prevalence of disease in the elderly is that the nor‐
mal aging process is associated with compositional changes and re‐
duced diversity of GM (Biagi et al., 2010). In parallel, normal aging 
is characterized by chronic low‐grade inflammation, a phenomenon 
commonly referred to as “inflammaging” (Franceschi et al., 2007). It 
is believed that this inflammation is, at least in part, attributable to 
alterations in GM (Buford, 2017). Additionally, aging is associated 
with changes in the serotonergic system which is also believed to 
contribute to increased prevalence of psychological disorders in the 
elderly (O'Mahony et al., 2015). The serotonergic system is regulated 
by GM (Table 1), therefore making it vulnerable to compositional and 
metabolic changes (O'Mahony et al., 2015; Rogers et al., 2016).
Given the sheer complexity of the systemic functioning of the 
human body, there are likely to be several other processes through 
which GM may be involved in predisposing individuals to the de‐
velopment of psychological illnesses. Further research into how GM 
influence predisposition to psychological illness will be useful in in‐
forming preventative strategies to circumvent the growing burden 
of such conditions. However, GM not only play a role in predisposing 
an individual to certain psychological illnesses as highlighted above, 
but also in the onset and maintenance of those negative health 
outcomes.
2.2 | Precipitating and perpetuating
While psychologists tend to focus heavily on social and environ‐
mental factors involved in the onset and maintenance of psycho‐
logical disorders, biological factors, such as GM composition, also 
contribute to these stages of disease. The maintenance of a diverse 
microbial ecosystem in the gut is essential for optimal host func‐
tion (Moloney et al., 2014; Sekirov et al., 2010). On the other hand, 
reduced diversity and microbial dysbiosis have been implicated in 
various psychological, neurological, metabolic, functional gastroin‐
testinal disorders, and autoimmune disease states (Blumstein, Levy, 
Mayer, & Harte, 2014). These include, but are not limited to, IBS 
(Jeffery et al., 2012; Tana et al., 2010), autism (Finegold et al., 2002), 
schizophrenia (Castro‐Nallar et al., 2015), myalgic encephalomyeli‐
tis/chronic fatigue syndrome (ME/CFS; Fremont, Coomans, Massart, 
& Meirleir, 2013; Wallis, Butt, Ball, Lewis, & Bruck, 2016), multiple 
sclerosis (Jangi et al., 2016), dementia (Alkasir, Li, Li, Jin, & Zhu, 
2017), stress (Knowles, Nelson, & Palombo, 2008), anxiety (Burch, 
2016), depression (e.g., Jiang et al., 2015), obesity (Ley, Turnbaugh, 
Klein, & Gordon, 2006), diabetes (Larsen et al., 2010), coronary ar‐
tery disease (Cui, Zhao, Hu, Zhang, & Hua, 2017; Emoto et al., 2017), 
and cancer (particularly colorectal cancer; Gagniere et al., 2016; 
Garrett, 2015). Current findings linking GM and disorders are, at 
this stage, associative and causative links are yet to be established. 
Additionally, it is unknown whether alterations in GM composition 
are the cause or consequence of disease. Given available evidence 
however, it is likely that this is a bidirectional, and cyclical, relation‐
ship as depicted in Figure 1.
2.2.1 | Stress
Stress has long been recognized as both a precipitating and per‐
petuating factor to various psychological conditions (Anisman & 
Zacharko, 1982; Corcoran et al., 2003). Given the crucial role of GM 
in the development and functioning of the HPA axis (Sudo, 2012), 
as well as their modulation of stress hormones CRF and cortisol 
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(Carabotti et al., 2015), the involvement of GM in the stress response 
is increasingly evident. This is further demonstrated by the ability 
to transfer stress‐prone phenotypes from one mouse to another via 
fecal transplantation (Collins, Kassam, & Bercik, 2013). Stress also 
activates an inflammatory response via the promotion of inflamma‐
tory cytokines (Liu, Wang, & Jiang, 2017). Given that inflammation 
is recognized as underlying many psychological and neurodegen‐
erative disorders (Almond, 2013; Miller & Raison, 2016; Rea et al., 
2016), stress then appears to play a role in both the etiology and 
maintenance of psychological illness via biological pathways, all of 
which are regulated by the GM. While this is reflective of a bot‐
tom‐up process whereby GM influence stress, substantial evidence 
also suggests the occurrence of a top‐down process through which 
stress regulates GM composition (Bailey et al., 2011; Gur, Worly, & 
Bailey, 2015; Knowles et al., 2008). The fact that both top‐down 
and bottom‐up processes have been well established demonstrates 
the complex cyclical and multidirectional relationship between GM, 
stress, and psychopathology.
2.2.2 | Socioeconomic status
There is an established association between low SES and several fac‐
tors negatively affecting health, one of which is poor diet (Darmon 
& Drewnowski, 2008; Shahar, Shai, Vardi, Shahar, & Fraser, 2005). 
Given that diet is the strongest environmental contributor to a prop‐
erly functioning GM (e.g., De Filippo et al., 2017; Garcia‐Mantrana 
et al., 2018), it is possible that the composition and/or metabolic 
activities of the GM is one of the mediating factors of the relation‐
ship between low SES and mental health outcomes. Another fac‐
tor associated with low SES is lower educational achievement (Sirin, 
2005) which may also be mediated by diet‐related changes in GM. 
Individuals who eat a poor‐quality diet (Western diet) have poorer 
performance on cognitive tasks (Khan et al., 2015) and poorer mental 
health (Jacka, Kremer, et al., 2011; Jacka, Mykletun, Berk, Bjelland, 
& Tell, 2011; Markus et al., 1998) compared to those who eat high‐
quality diets. In addition, an association has been found between the 
consumption of a Western diet and decreased left hippocampal vol‐
ume (Jacka, Cherbuin, Anstey, Sachdev, & Butterworth, 2015) with 
hippocampal volume being related to cognition (Choi et al., 2016) 
and mood (Frodl et al., 2006). It is likely the GM mediate this rela‐
tionship through their production of SCFAs and BDNF which have 
been found to be involved in neurogenesis and neuronal protection 
in mouse models (Canani, Di Costanzo, & Leone, 2012; Lee, Duan, & 
Mattson, 2002; Sun et al., 2015). Ultimately, poorer performance on 
cognitive tasks and poorer mental health limit a person's educational 
attainment (Eisenberg, Golberstein, & Hunt Justin, 2009; Fletcher, 
2010; McLeod & Fettes, 2007).
2.3 | Protective
Considering the protective abilities of GM or indeed, specific mi‐
croorganisms, has the potential to revolutionize the treatment of 
psychological conditions (Kali, 2016; Mazzoli & Pessione, 2016; 
Sampson & Mazmanian, 2015). The addition of GM modulation to an 
individual's treatment plan may be the missing link in explaining and 
counteracting the alarming increase in the disease burden of com‐
mon mental disorders.
2.3.1 | Lifestyle factors
Healthy eating and exercise have long been promoted as being 
protective factors against both physiological and psychological 
conditions. Evidence suggests that one of the physiological mech‐
anisms through which healthy eating and exercise affect health is 
the influence these factors have on the composition and metabolic 
activity of GM (Mika et al., 2015; Welly et al., 2016). Essentially, a 
high‐quality diet and exercise provide the GM with the resources 
they require to maintain optimal host function. While the influ‐
ence of diet on GM composition is widely researched, that of ex‐
ercise on GM receives less attention. However, exercise has been 
shown to enrich microbial diversity, improve the Bacteroidetes‐to‐
Firmicutes ratio, and support the growth of SCFA‐producing bac‐
teria which have immunomodulatory effects (Monda et al., 2017). 
This suggests that like diet, the beneficial outcomes of exercise 
may be mediated by GM which have downstream effects on men‐
tal health.
2.3.2 | Pre‐ and probiotics
Both pre‐ and probiotics have also been demonstrated to have psy‐
chotropic like effects in healthy volunteers as well as those suffering 
from conditions such as depression and chronic fatigue syndrome 
(CFS; Akkasheh et al., 2016; Messaoudi et al., 2011; Rao et al., 2009). 
Probiotics showing positive effects on mental health are referred 
to as psychobiotics (Dinan, Stanton, & Cryan, 2013). Studies have 
demonstrated that various probiotic formulations (mostly including 
Lactobacillus and Bifidobacterium species) have the ability to improve 
mood in healthy (no reported diagnoses of allergic, neurological, 
or psychological conditions) men and women (Benton, Williams, & 
Brown, 2007; Messaoudi et al., 2011; Steenbergen, Sellaro, Hemert, 
Bosch, & Colzato, 2015). In a placebo‐controlled study, Yamamura 
et al. (2009) found a probiotic formulation to improve sleep efficacy 
and number of awakenings (as measured by actigraphy) in an elderly 
(60‐ to 81‐year‐old) sample. Moreover, a study using fMRI revealed 
altered activity in brain regions responsible for emotion and sensa‐
tion processing in women following four weeks of probiotic formula‐
tion intake compared to women who received a placebo (Tillisch et 
al., 2013). Also in a placebo‐controlled study, participants who took 
a prebiotic (Bimuno‐galactooligosaccharides) daily for three weeks 
showed significantly lower salivary cortisol levels and decreased at‐
tentional vigilance to negative versus positive information (Schmidt 
et al., 2015). These findings were similar to those of a study that in‐
volved the administration of an SSRI (Murphy, Yiend, Lester, Cowen, 
& Harmer, 2009).
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2.3.3 | Fecal microbial transplant
The increasing popularity of fecal microbial transplant (FMT) in 
treating various conditions including but not limited to GI disorders 
(Brandt & Aroniadis, 2013), Parkinson's disease (Ananthaswamy, 
2011), autism (Aroniadis & Brandt, 2013), and ME/CFS (Borody, 
Nowak, & Finlayson, 2012) is perhaps due to the proliferation of 
research associating microbial dysbiosis to a range of disorders. In 
humans, the efficacy of FMT has been shown for conditions such 
as ulcerative colitis (Shi et al., 2016), but has not yet been demon‐
strated in treating psychological conditions. It does however offer 
a promising avenue given strong evidence suggesting a role of GM 
in the pathogenesis of psychological conditions (Evrensel & Ceylan, 
2016). Animal models suggest that FMT is an effective way to ame‐
liorate abnormal physiology and function (e.g., Sudo et al., 2004); 
however, clinical trials are required to demonstrate whether this ap‐
proach is equally effective in humans. Additionally, further research 
is required into the possible risks associated with FMT. While FMT 
has promising therapeutic potential, Alang and Kelly (2015) present 
a case study of a patient who developed obesity following FMT 
treatment from an overweight, but otherwise healthy donor. As GM 
are associated with numerous physiological and psychological condi‐
tions, FMT could theoretically result in the transference of any such 
condition from donor to recipient (Bunnik, Aarts, & Chen, 2017). As 
such, it is clear that great care must be taken when screening and 
selecting potential donors. There is still much to learn about the as‐
sociations between GM and both physiological and psychological 
conditions, and therefore, potential long‐term risks of FMT may yet 
to emerge.
3  | CRITICISMS OF CONVENTIONAL 
TRE ATMENT WITH RESPEC T TO GM
Conventional treatment of psychological disorders typically in‐
volves pharmacological intervention such as psychotropics and/or 
other medications to alter brain chemistry (e.g., Bystritsky, Khalsa, 
Cameron, & Schiffman, 2013; Lieberman et al., 2005). Although ben‐
eficial, such treatments may induce undesirable side effects includ‐
ing, but not limited to, nausea, sleep disturbance, weight gain, and 
sexual dysfunction (Ferguson, 2001) all of which may themselves 
be a result of microbe‐mediated drug metabolism (Enright, Joyce, 
Gahan, & Griffin, 2017). Despite the ever increasing reliance on phar‐
macotherapy (Kallivayalil, 2008; Vozeh, 2003), disease states remain 
relatively stable which suggests the need for auxiliary treatment op‐
tions and/or targets which take into account several body systems, 
including the GM. Many psychotropic drugs, known for their influ‐
ence on CNS receptor function, also demonstrate antimicrobial ef‐
fects (Kalayci, Demirci, & Sahin, 2014) which may have unintended 
consequences on the BGMA. This is particularly true of many SSRIs 
commonly used to treat depression and anxiety disorders.
In addition to having direct antimicrobial effects, Ayaz et al. 
(2015) found that sertraline (an SSRI) augments the effectiveness 
of several antibiotics by increasing their inhibitory zone. As such, 
chronic use of these drugs can induce potentially deleterious alter‐
ations in GM (Macedo et al., 2017). This may partially explain treat‐
ment resistance, although further research is needed to support this 
notion. Likewise, psychological interventions (e.g., cognitive behav‐
ior therapy) also target the brain via a focus on cognitions to affect 
behavioral change. This top‐down process has demonstrated effi‐
cacy in the treatment of functional gastrointestinal disorders such 
as IBS (Boersma et al., 2016; Palsson & Whitehead, 2013); however, 
research is needed to determine whether purely psychological in‐
terventions can enact changes in GM. By continuing to treat vari‐
ous disorders and symptoms through pharmacological intervention 
without considering the etiology of initial chemical imbalances, it is 
unlikely that rates of morbidity will decline. The net effect of ignor‐
ing etiology at the expense of treatment is therefore an increased 
burden upon individuals who are affected by disease, and wider 
society.
4  | REDEFINING WHO WE ARE
There is currently a shift away from thinking of host–microbe interac‐
tions in such binary terms toward appreciating the complexity of the 
relationship between the two. Binary distinctions between host and 
microbiota remain useful only in so far as to aid our understanding of 
the role of GM in psychological well‐being, which is still in its infancy. 
However, emerging nomenclature such as “holobiont” acknowledges 
that GM are not a separate entity but are instead an integral and in‐
separable part of human biology (Schnorr, Sankaranarayanan, Lewis, 
& Warinner, 2016; Theis et al., 2016). This concept is supported by 
the coevolution of humans and their microbes. The concept that the 
ratio of bacterial cells to human cells is approximately 1:1 (recently 
revised down from previous estimations of 10:1; Sender, Fuchs, & 
Milo, 2016) pays homage to the importance of respecting GM in the 
conceptualization of human health and well‐being. This reconcep‐
tualization of what makes us human also provides a biological and 
tangible basis for explaining and treating psychological illnesses that 
can often be considered abstract.
5  | CHALLENGES AND THE WAY 
FORWARD
Understanding the multidirectional relationship between GM and 
the nervous system is hindered by its inherent complexity (Mazzoli 
& Pessione, 2016). However, while still in its infancy, interdiscipli‐
nary research has uncovered novel ways of conceptualizing disease. 
While theoretically relevant, research into the BGMA also has im‐
portant practical implications, offering a more holistic approach to 
treatment and prevention of psychological illness. While this new 
field of research is promising, it remains unclear which factors, and 
in which combination, alter the balance between symptomatic and 
asymptomatic outcomes.
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The sheer number of confounding variables makes it difficult 
to establish causational links between GM and symptomatology. 
However, as understanding of the GM advances, so too will research 
methodology and technology. It is only with continued research into 
the link between GM and psychological illness that we will be able to 
elucidate the true extent to which our resident microbes contribute 
to mental health. As the majority of studies regarding the role of 
GM in both physiological and psychological health and disease have 
been conducted using animal models, clinical trials with human sam‐
ples are imperative to the advancement of knowledge and ultimately 
practical application.
As the burgeoning research into the relationship between GM 
and psychological health outcomes gathers momentum, so too 
does the call to action for psychologists to embrace the microbi‐
ome as a potential factor in explaining, treating, and preventing 
mental illness. This is an important paradigm shift which must 
occur within the discipline of psychology in order to keep up to 
date with the most current and complete knowledge of the human 
body and mind which translates into providing the best possible 
care for clients. While it is unnecessary and impractical to expect 
psychologists to develop a detailed understanding of the influence 
of GM on mental health, it is important that the role of the GM is 
acknowledged, especially in the absence of clear social and emo‐
tional factors. Facilitating this paradigm shift may require change 
at a “grass roots” level, where psychobiology is better integrated 
into higher education psychology degrees. Additionally, profes‐
sional development courses regarding the role of the GM in mental 
health should be established and promoted to current practicing 
psychologists who can use this information to provide more com‐
plete care for their clients.
The fact that GM are able to influence psychological functioning 
is an exciting and encouraging prospect, which begs for multidisci‐
plinary approaches to both research and practice. In terms of prac‐
tical implications, increasing our understanding of the mechanisms 
that mediate communication processes between GM and host has 
the potential to inform strategies to limit the damaging aspects of 
this communication. This will provide new avenues of treatment for a 
wide range of symptoms and disorders (Freestone, 2013) as well as to 
promote good health. This will require a substantial shift away from 
the reductionist approaches that see us working exclusively in our 
specific field. This is not to suggest that psychologists should become 
expert in areas outside of their field, but instead to understand and ac‐
knowledge that the best way forward is a multidisciplinary approach 
to the treatment and prevention of mental illness. A shift toward a 
multidisciplinary, and therefore more holistic, approach will provide 
an opportunity to better understand the etiology of disease which 
requires the expertise of several disciplines and a consideration of 
key body systems, including the GM, as intertwined and inseparable. 
In light of the evidence research has provided thus far, psychologists 
working as part of multidisciplinary teams with other professionals 
such as nutritionists, gastroenterologists, and microbiologists must 
seriously consider the inclusion of dietary plans, pre‐ and probiotics, 
and potentially even FMT in the treatment plans of their clients, in 
conjunction with conventional psychological treatments.
It is not the contention of this paper to claim that ameliorating 
gut health is the panacea to all psychological disorders and symp‐
tomatology. Instead, it is to demonstrate the complex intercon‐
nectivity between multiple body systems in disease processes, 
from etiology through to treatment, and ideally prevention. In 
support of the call to action by Allen et al. (2017), the discipline of 
psychology must shift away from its CNS‐centric conceptualiza‐
tion of disease and symptom‐centered disease treatment models 
toward a multidisciplinary approach to treatment and prevention. 
This paradigm shift will empower psychologists to better treat and 
care for their clients. A multidisciplinary approach where health‐
care professionals across a variety of disciplines have a united ap‐
proach to treatment and prevention will also empower the public 
to better understand and take control of their physiological and 
psychological health. It is only through this shared awareness that 
the healthcare community can make inroads into improving the 
mental health of current and future generations.
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